JICHI MEDICAL UNIVERSITY
🇯🇵Japan
- Country
- 🇯🇵Japan
- Ownership
- Private
- Established
- 1975-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.jichi.ac.jp
A Study to Define the Distribution of Type of Hypertension in Asia by Blood Pressure Monitoring at Home (Asia BP@Home)
Completed
- Conditions
- Hypertension
- First Posted Date
- 2017-03-30
- Last Posted Date
- 2018-04-17
- Lead Sponsor
- Jichi Medical University
- Target Recruit Count
- 1462
- Registration Number
- NCT03096119
- Locations
- 🇯🇵
Jichi Medical University, Tochigi, Japan
SGLT-2i and ARB Combination Therapy in Patients With T2DM and Nocturnal Hypertension (SACRA Study)
Phase 4
Completed
- Conditions
- Nocturnal HypertensionT2DM (Type 2 Diabetes Mellitus)
- Interventions
- Drug: PlaceboDrug: Empagliflozin
- First Posted Date
- 2017-02-10
- Last Posted Date
- 2018-03-27
- Lead Sponsor
- Jichi Medical University
- Target Recruit Count
- 174
- Registration Number
- NCT03050229
- Locations
- 🇯🇵
Kotake Hospital, Fukuoka, Japan
🇯🇵Onga Hospital, Fukuoka, Japan
🇯🇵Ishiguro Clinic, Gifu, Japan
To Compare the Effectiveness of Suvorexant vs Placebo on Sleep Pressure in Hypertensives With Insomnia
- First Posted Date
- 2016-07-29
- Last Posted Date
- 2019-08-05
- Lead Sponsor
- Jichi Medical University
- Target Recruit Count
- 82
- Registration Number
- NCT02849184
- Locations
- 🇯🇵
Yamasaki family clinic, Hyogo, Japan
🇯🇵Takahira Internal Medicine Clinic, Fukuoka, Japan
🇯🇵Yagi hospital, Tokyo, Japan
AADC Gene Therapy for Parkinson's Disease
Phase 1
Terminated
- Conditions
- Parkinson Disease
- Interventions
- Genetic: Cohort1Genetic: Cohort2
- First Posted Date
- 2015-04-16
- Last Posted Date
- 2019-08-09
- Lead Sponsor
- Jichi Medical University
- Target Recruit Count
- 2
- Registration Number
- NCT02418598
- Locations
- 🇯🇵
Jichi Medical University, Shimotsuke, Tochigi, Japan
Gene Therapy for B-Cell Non-Hodgkin Lymphoma Using CD19 CAR Gene Transduced T Lymphocytes
Phase 1
- Conditions
- Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma
- Interventions
- Drug: Cyclophosphamide or BendamustineGenetic: Dose Level 1Genetic: Dose Level 2Genetic: Dose Level 3Genetic: Dose Level -1
- First Posted Date
- 2014-05-09
- Last Posted Date
- 2014-11-06
- Lead Sponsor
- Jichi Medical University
- Target Recruit Count
- 18
- Registration Number
- NCT02134262
- Locations
- 🇯🇵
Jichi Medical University, Shimotsuke, Tochigi, Japan
Effect of Eplerenone in Elderly Hypertensive Early Stage Chronic Kidney Disease (CKD) Patients
- First Posted Date
- 2011-02-24
- Last Posted Date
- 2012-07-06
- Lead Sponsor
- Jichi Medical University
- Registration Number
- NCT01302236
Effects of Aliskiren in Elderly Hypertensive Chronic Kidney Disease (CKD) Patients
- First Posted Date
- 2011-01-26
- Last Posted Date
- 2012-10-22
- Lead Sponsor
- Jichi Medical University
- Target Recruit Count
- 23
- Registration Number
- NCT01284114
- Locations
- 🇯🇵
Kurosu Hospital, Sakura, Tochigi, Japan
🇯🇵Niimi city Yukawa National health insurance clinic, Niimi, Okayama, Japan
🇯🇵Konan Hospital, Oyama, Tochigi, Japan
The Japan-Combined Treatment With Olmesartan and a Calcium Channel Blocker Versus Olmesartan and Diuretics Randomized Efficacy Study (J-CORE)
Phase 4
Completed
- Conditions
- Hypertension
- Interventions
- First Posted Date
- 2008-02-05
- Last Posted Date
- 2008-11-20
- Lead Sponsor
- Jichi Medical University
- Target Recruit Count
- 220
- Registration Number
- NCT00607035
- Locations
- 🇯🇵
Jichi Medical University School of Medicine, Tochigi, Japan
© Copyright 2025. All Rights Reserved by MedPath